Vogenx (VOGX) vs Whitehawk Therapeutics (WHWK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Whitehawk Therapeutics is the larger company by market cap ($181.2 million vs $176.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | VOGX | WHWK |
|---|---|---|
| Share price | $11.87 | $3.07 |
| Market cap | $176.33M | $181.16M |
| 1-day change | -7.30% | -1.60% |
| YTD return | — | +26.86% |
| 1-year return | — | +45.50% |
| 5-year return | — | -86.36% |
| EPS (TTM) | $-0.89 | $-1.10 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $7.14M |
| Revenue growth (YoY) | — | -72.50% |
| Net income (latest FY) | — | $-20.60M |
| Gross margin | — | 89.36% |
| Operating margin | — | -1601.12% |
| Net margin | — | -288.26% |
| 52-week high | $38.41 | $5.50 |
| 52-week low | $11.51 | $2.10 |
| Distance from 52-week high | -69.10% | -44.13% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +363.35% | +151.14% |
| Average volume | 128.78K | 348.68K |
| Shares outstanding | 14.86M | 59.01M |
| Employees | 4 | 37 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Vogenx
VOGX stock →Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis.
Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees
About Whitehawk Therapeutics
WHWK stock →Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer.
Health Care · Biotechnology: Pharmaceutical Preparations · 37 employees
VOGX vs WHWK FAQ
Which is bigger, Vogenx or Whitehawk Therapeutics?
Whitehawk Therapeutics (WHWK) is larger, with a market capitalization of $181.16M compared with $176.33M for Vogenx (VOGX).
Are Vogenx and Whitehawk Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.